Developing Therapies for Parkinson’s
The Lancet highlights the work we do with our AMP-PD partners in enabling meaningful progress in the development of new therapies to treat Parkinson’s disease.
Aligning Science Across Parkinson’s Awards $161 Million in Grants
Philanthropy News Digest featured ASAP in this article detailing what our grantees hope to accomplish with their research.
Aligning Science Across Parkinson’s awards $161 million in grants
Philanthropy News Digest covers ASAP’s first round of grants totalling$161 million in support of Parkinson's research.
Researchers Describe Details of Protein Linked to Genetically Inherited Parkinson’s Disease
This article from News Medical Life Sciences highlights new studies describing unprecedented details of a protein linked to genetically inherited Parkinson's disease.
ASAP and cOAlition S
ASAP is committed to making full and immediate open access a reality. The future is science without publication paywalls.
Coordinating a new approach to basic research into Parkinson’s disease
Point of view from ASAP scientific director, Randy Schekman, PhD and managing director, Ekemini A. U. Riley, PhD.
